总暴露与全静态负荷和心血管疾病风险的关联
Elon Barbee1, Emmanuel Obeng-Gyasi2
1Department of Built Environment, North Carolina A&T State University, Greensboro, North Carolina, USA.
概括
这项研究发现,在美国成年人中,暴露和心血管疾病风险标志物之间没有显著的联系. 较高的含量与较高的年龄有关,这表明年龄是暴露研究中的关键因素.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 心血管疾病流行病学
背景情况:
- 是一种具有潜在健康影响的有毒元素.
- 了解暴露对公共健康至关重要.
- 心血管疾病 (CVD) 仍然是导致死亡的主要原因.
研究的目的:
- 为了研究暴露与全静电负荷之间的关联.
- 检查暴露与心血管疾病风险标志物之间的关系.
- 分析来自美国代表性人口的数据.
主要方法:
- 尿样被用来测量含量.
- 评估了全静电负荷和心血管疾病风险标志物.
- 对美国非机构化的平民人口数据进行了统计分析.
主要成果:
- 尿液中含量较高的个体年龄明显大.
- 在尿道总水平和心血管变量之间没有发现显著的关联.
- 这项研究强调了对健康影响的复杂性.
结论:
- 目前对暴露的测量可能无法完全捕捉心血管疾病风险.
- 需要对特定的物种和长期暴露标志物的进一步研究.
- 全面的生物标志物评估对于评估对健康的影响至关重要.
相关概念视频
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Coronary Artery Disease IV: Preventive Measures
792
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
792
Atherosclerosis III: Management
556
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
556
Psychoneuroimmunology: Cardiovascular Disease
645
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
645
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
687
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
687
Atherosclerosis I: Introduction
1.8K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K

